Personal tools

Coexpression cluster:C912

From FANTOM5_SSTAR

Revision as of 14:59, 21 May 2012 by Autoedit (talk | contribs)
Jump to: navigation, search


Full id: C912_CD14_mesothelioma_tenocyte_migratory_mesenchymal_spleen_CD14CD16



Phase1 CAGE Peaks

Hg19::chr16:30727305..30727313,+p@chr16:30727305..30727313
+
Hg19::chr22:35777079..35777096,+p1@HMOX1
Hg19::chr22:35782669..35782693,+p8@HMOX1
Hg19::chr22:35782737..35782763,+p6@HMOX1
Hg19::chr22:35782834..35782851,+p4@HMOX1
Hg19::chr22:35782917..35782934,+p7@HMOX1
Hg19::chr22:35783010..35783044,+p2@HMOX1
Hg19::chr22:35789482..35789516,+p5@HMOX1
Hg19::chr22:35790125..35790153,+p3@HMOX1


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
CD14-positive, CD16-negative classical monocyte3.62e-2342
monopoietic cell2.07e-2163
monocyte2.07e-2163
monoblast2.07e-2163
promonocyte2.07e-2163
classical monocyte1.47e-2045
macrophage dendritic cell progenitor3.07e-2065
myeloid leukocyte2.46e-1876
myeloid lineage restricted progenitor cell3.34e-1870
multi fate stem cell5.38e-18430
somatic stem cell4.80e-16436
granulocyte monocyte progenitor cell5.35e-1671
stem cell1.73e-15444
mesodermal cell3.69e-13119
connective tissue cell8.14e-11365
somatic cell5.02e-10591
mesenchymal cell1.29e-09358
non-terminally differentiated cell1.33e-09180
endothelial cell6.56e-0935
meso-epithelial cell5.76e-0844
endothelial cell of vascular tree9.33e-0824
lining cell1.17e-0757
barrier cell1.17e-0757
muscle precursor cell3.70e-0757
myoblast3.70e-0757
multi-potent skeletal muscle stem cell3.70e-0757
contractile cell8.38e-0759
fibroblast9.20e-0775
Uber Anatomy
Ontology termp-valuen
musculoskeletal system7.81e-23167
lateral plate mesoderm3.08e-21216
mesoderm5.14e-20448
mesoderm-derived structure5.14e-20448
presumptive mesoderm5.14e-20448
immune system1.82e-18115
bone marrow2.92e-1680
hemolymphoid system6.22e-15112
bone element1.24e-1486
skeletal element3.38e-14101
skeletal system3.38e-14101
multi-cellular organism5.73e-13659
hematopoietic system6.15e-13102
blood island6.15e-13102
vessel4.84e-1169
anatomical system5.08e-11625
anatomical group6.01e-11626
splanchnic layer of lateral plate mesoderm1.51e-1084
connective tissue2.83e-10375
blood vessel1.03e-0960
epithelial tube open at both ends1.03e-0960
blood vasculature1.03e-0960
vascular cord1.03e-0960
vasculature1.29e-0979
vascular system1.29e-0979
epithelial tube2.64e-09118
cardiovascular system3.27e-09110
circulatory system5.41e-09113
systemic artery8.50e-0933
systemic arterial system8.50e-0933
artery1.06e-0842
arterial blood vessel1.06e-0842
arterial system1.06e-0842
somite2.65e-0783
paraxial mesoderm2.65e-0783
presomitic mesoderm2.65e-0783
presumptive segmental plate2.65e-0783
trunk paraxial mesoderm2.65e-0783
presumptive paraxial mesoderm2.65e-0783
muscle tissue2.75e-0763
musculature2.75e-0763
musculature of body2.75e-0763
dermomyotome3.60e-0770
skeletal muscle tissue4.01e-0761
striated muscle tissue4.01e-0761
myotome4.01e-0761
trunk mesenchyme6.21e-07143


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.